12 August 2026
SNIPR001 used under eIND for resistant E. coli malakoplakia
A 65-year-old kidney transplant patient received SNIPR001 after an emergency investigational new drug application; an intra-abdominal mass fell from 744.6 cm3 to 82 cm3 over a year.
source: clinicaltrialsarena.com
The full briefing is in the app.